Pulmonary maturation in diabetic pregnancy has been studied in the 20-day-old fetuses of manifest diabetic rats. The animals were either untreated or treated with insulin. The diabetic state was induced by a single IV injection of streptozotocin given about 2 wk before the onset of pregnancy. The biosynthesis of lung surfactant was estimated by monitoring the rate of incorporation of ImethJ~l-3Hlcholine into phosphatidylcholine and lysophosphatidylcholine in fetal lung slices.
Summary
Pulmonary maturation in diabetic pregnancy has been studied in the 20-day-old fetuses of manifest diabetic rats. The animals were either untreated or treated with insulin. The diabetic state was induced by a single IV injection of streptozotocin given about 2 wk before the onset of pregnancy. The biosynthesis of lung surfactant was estimated by monitoring the rate of incorporation of ImethJ~l-3Hlcholine into phosphatidylcholine and lysophosphatidylcholine in fetal lung slices.
I n the untreated group, the biosynthesis of both phosphatidylcholine and lysophosphatidylcholine were decreased in the fetal lung. Insulin treatment abolished the decrease in the phosphatidylcholine biosynthesis, whereas the lysophosphatidylcholine biosynthesis reamined depressed. Light and transmission electron microscopical studies indicated a delayed pulmonary maturation in the untreated offspring accompanied by a decreased cytoplasmic content of glycogen in the alveolar epithelial cells.
Speculation
I t is suggested that, in diabetic pregnancy, respiratory distress syndrome becomes manifest after a diminished availability of surface-active dipalmitic phosphatidylcholine in the fetal lung, resulting from a specific inhibition of the lysophosphatidylcholine pathway.
Respiratory distress syndrome (RDS) is a major cause of neonatal morbidity and mortality in diabetic pregnancy (39) . RDS is the clinical manifestation of pulmonary immaturity. The maturation process involves a steroid-mediated increase in the biosynthesis of various surface-active phospholipids (2. 14. 15. 17. 36) . especially dipalmitic phosphatidylcholine (PC) and phosphatidylglycerol (PG), in the type 11 cell of the alveolar lining ( 19, 29) . In these cells. the surface-active material formed is temporarily stored in the lamellar bodies before extrusion to the extracellular space (9.28) . In all species studied. the major pathway of PC biosynthesis involves the incorporation of CDP-choline into diglyceride ( I I. 20) . This pathway accounts for about 97% of the total PC formed in the fetal rat lung. The biosynthesis of PC reaches a peak 2 days before birth (34. 44) at a time when the glycogen content of the type I1 cell is declining in a manner inversely proportional to the phospholipid content of the cell (5, 26. 34) . In diabetic pregnancy. this maturation process is somehow disturbed. possibly as a result of alterations in the insulin level in the fetal circulation. However. there are conflicting reports concerning the effect of insulin on the biosynthesis of PC (10. 41) . Recently. the importance of hyperinsulinemia for the development of RDS in diabetic pregnancy has been questioned because no increase in cord blood C-peptide levels could be detected in human offspring subsequently developing RDS (42). The precise cause of the delayed fetal pulmonary maturation in diabetic pregnancy therefore remains unresolved.
The aim of this investigation was to study. in biochemical and morphologic terms. pulmonary maturation in offspring of rats with severe streptozotocin-induced diabetes ( c -Ref. 12 ).
MATERIALS AND METHODS
Manifest diabetes (MD) was induced in 3-month-old virgin Sprague-Dawley rats by a single IV injection of streptozotocin (kindly donated by W. E. Dulin. Upjohn Co.. Kalamazoo. MI) at a dose of 45 mg/kg body weight. Animals with a nonfasting blood glucose concentration of more than 22 mmoles/liter one wk after the injection were classified as MD. Treatment with bovine Novo Ultralente Insulin (Novo Co.. Copenhagen. Denmark) was commenced in about one-half of the diabetic animals. The dose. ranging from 2 to X unitslday. was adjusted according to the blood glucose concentration. which was determined twice a wk. Weightmatched normal rats ( N ) of the same age served as controls. The animals were mated 2 to 4 wk after the streptozotocin treatment, and daily vaginal smears were examined for the presence of sperm. The duration of pregnancy could therefore be determined with an accuracy of k 6 hr.
On gestational day 20. the rats were killed by a blow on the neck. and the fetuses were quickly dissected from the uterus and decapitated before any spontaneous breathing had occurred. The right lungs were excised and pooled litterwisi in Hanks' solution. Maternal and fetal blood was collected for determination of serum insulin (23) and glucose concentrations (Beckman Glucose Analyzer 2: Beckman Inc.. Fullerton, CA). To determine the rate of choline incorporation into PC and lysophosphatidylcholine (LPC), the pooled lungs were chopped with a pair of scissors into pieces of approximately I mm,' and transferred into a vessel containing 100 p1 Krebs-Ringer bicarbonate buffer (pH 7.6) equilibrated with 0 2 : C 0 2 (95%:5%) and choline chloride (0.01 mmole/ liter). After a 10-min preincubation period in a shaking water bath at +3X°C. the medium was changed. and 10 pCi of ['Hlmethylcholine chloride (specific activity. 6.4 Ci/mmole) were added. The incorporation of label was terminated after 90 min by addition of 200 p1 I mM choline chloride. and the incubation was extended for a further 10 min to dilute the radioactivity. The lung samples were subsequently washed twice in a salt solution (16) and sonicated for 10 sec (Ultrasonic disintegrator: 60 W. MSE. London. United Kingdom) in 150 p1 of the wash solution. Duplicate 10-p1 samples of the homogenate were removed for determination of DNA content. The lipids of the remaining homogenate were then extracted for 2 hr with chloroform:methanol (2:l). After four washings to remove water-soluble radioactivity (16) , 30 p1 of a solution of mixed egg yolk phospholipids (24 mg/ml) (Vitrum AB. Stockholm. Sweden) was added as a carrier. The lower phase. containing the phospholipids. was evaporated to dryness under a stream of pure nitrogen. The extracts were then dissolved in 100 pl of chloroform:methanol (2: 1). and 40 p1 were spotted on precoated plates of Silica Gel G (E. Merck A. G.. Darmstadt. Germany). The phospholipids were separated in a solvent system of chloroform:methanol:acetic acid:@ I M NaKO., in water (50:25: 7:3 by volume) (40). The phospholipid spots were identified in ultraviolet light after spraying the plates with 2'7'-dichlorofluorescein (0.2 mg/ml). The spots corresponding to the PC and LPC markers were scraped off into scintillation vials containing 0.5 ml . . . , ofchance ditf'erences between the groups were estimated according to Student's two-tailed t test.
Three fetuses from each experimental group. but from different litters. were used for morphologic studies. To achieve proper fixation, glutaraldehyde (2.5";) in cacodylate buffer (pH 7.4) was gently injected into the respiratory tract immediately after the decapitation of the fetus. The chest wall was then opened. and fixatlve was pipeted onto the exposed lungs. The lungs were removed and cut to ensure thorough lixation. After 2 days fixation. the specimens were dehydrated in an ethanol. followed by an ethanol-propylene oxide series, and linally embedded in Epon. Toluidine blue was used to stain the light microscopical sections. The sections taken for transmission electron microscopy were cut on a LKB Ultrotome (LKB-Produkter AB. Stockholm. Sweden). stained with uranyl acetate, and lead citrate and examined in a JEOL IOOB transmission electron microscope (JEOL AB. Sundbyberg. Sweden).
RESULTS

C'OURSt. A N D TERMINATION OF PRt(;NAN('Y
The MD animals exhibited continuous polyuria and glucosuria throughout pregnancy, findings that were virtually absent in the insulin-treated manifest diabetic (MDI) group. The insulin dose was not significantly altered during gestation in the MDI group and was 5.2 & 0.3 IU/day ( n = 15) at the end ofpregnancy. Table  I shows the blood glucose concentration of mothers and fetuses at gestational day 20. Despite the pronounced hyperglycemia in the M D group. there were no differences between the fetal serum insulin values of the N, MD. and MDI animals ( c - Table I ) . Table 2 shows the strikingly reduced body weight of the M D offspring as compared to the controls. whereas no significant differences between the litter sizes could be found.
The biosynthesis of both PC and LPC were decreased in the lungs o l the M D Iktuseh as co~nparcd to both thc N and MDI Numbers in parentheses, number of maternal rats or number of litters. " P < 0.001 versus N.
In the LM studies, the lungs of N and MDI fetuses showed developed alveolar ducts. which accounted tbr about 50% of the section surfaces (Fig. IA) . In contrast, the lungs of MD fetuses exhibited abundant mesenchyme and only a few completely developed alveolar ducts (Fig. In) . The transmission electron microscopy studies showed alveolar epithelium in the N and MDI fetuses. which was differentiated into type I and type 11 cells (Fig.  2A) . This contrasted to the less well differentiated pulmonary epithelium found in the lungs of the MD fetuses (Fig. 2 B ) . Lamellar bodies were present in the intracellular matrix in all groups. but could not be found in extracellular clusters in the MD -.
fetuses. An apparent decrease in cytoplasmic glycogen was noticed in the MD fetuses, whereas no differences between the N and MDI groups were observed. Glycogen-free spaces (cf: Ref. 26) tended to be larger and more numerous in the MDI group.
In diabetic pregnancy, fetal hyperinsulinemia is thought to be responsible for many of the features of diabetic fetopathia (38). including a disturbed pulmonary maturation (7) . Unlike the human situation, fetal hyperinsulinemia does not appear to be a feature of severe diabetes in rats (12. 27) . We have previously demonstrated a diminished insulin content and biosynthesis in the offspring of diabetic rats (12. 13) . which may well explain the low fetal weight in the M D group because insulin is considered to be the primary growth-promoting factor during fetal life (38). In support of this hypothesis. insulin treatment readily normalized the fetal weights. The improved metabolic control in the MDI animals resulted in fetal blood glucose values about two-fold higher than those in the normal group. but without an increase in the serum insulin levels ( Table 2 ). This experimental system. therefore. permits the study of fetal pulmonary maturation in maternal diabetes without the influence of fetal hyperinsulinemia.
In the MD group, the morphologic findings of abundant mesenchyme and only a few alveolar ducts lined with undifferentiated epithelial cells indicated a severely disturbed pulmonary maturation. This lack of pulmonary differentiation could indicate a deficient glucocorticoid action. but an antagonism between insulin 
No/litter
Body wt (g) N 14.5 + 1.1' (11)" 3.5 + 0.1
11.7+0.6 - (15) 3.0 + 0.1 (15) ' Mean -t S.E.
Numhcrb in parentheses. numher of litters
,' P c 0.001 versus N. ' n, number of litters. ' Mean k S.E.
" P < 0.05 versus N. 9 P 0.00 1 versus N.
' P < 0.001 (MD versus MDI). and cortisol. as proposed by other investigators ( 10. 2 I. 37.4 1.43) seems unlikely. due to the absence of hyperinsulinemia in the MD offspring. The rise in fetal serum cortisol levels near term (8. 24, 35 ) is considered to be necessary for the last part of normal lung maturation (33). The successively lowered fetal blood glucose concentration observed in the last third of normal rat and human pregnancy (12) may be of major importance in triggering this "steroid surge" (8, 18.35) . The constant hyperglycemia in the MD fetuses could therefore remove the primary stimulus for increased glucocorticoid secretion and thus impede the normal acceleration of lung differentiation in the late gestation. In addition. a decrease in the number of glucocorticoid receptors in the rat fetal lung (4) may help to explain the delayed pulmonary maturation in diabetic pregnancy.
In normal rat pregnancy, the developing type I1 cells show low phospholipid and high glycogen contents before gestational day 20. However. the functionally insulinopenic MD fetuses exhibited an apparently decreased lung glycogen content and exhibited a depressed PC biosynthesis. the latter finding confirming a recent report (4) in a similar diabetic rat model. Inasmuch as glycogen is considered to be the major carbohydrate source for PC biosynthesis (34). a shortage of substrate could explain. at least in part. the decreased PC biosynthesis in the MD fetuses. Conversely. however. Gross and Smith (21) reported decreased amounts of lamellar bodies in fetal rat lung explants cultured in an excess of insulin (1000 pU/ml). In contrast to our in vivo model. they also found an increased pulmonary glycogen content. These authors therefore proposed that insulin. by stimulating glycogen biosynthesis, diverted carbohydrate precursors from the biosynthesis of surfactant phospholipids.
Treatment of the diabetic rats with long-acting insulin improved the metabolic control. giving a near-normal maternal blood glucose concentration. Fetal lung morphology in the MDI offspring closely resembled that of the normal rats. The disturbed PC biosynthesis was normalized. which is compatible with the idea of a restored balance between synthesib of glycogen and utili~ation of glycogen as a precursor for phospholipid production.
The incorporation of choline into LPC in the MDI fetuses was still only 50'7 of that found in the normal fetuses. The importance of LPC as an intermediate in the formation of dipalmitic PC has recently been demonstrated ( 1. 22). The decreased activity of the LPC pathway in the MD fetuses, which could only be partly corrected by insulin treatment. may have produced surfactant with a lowered content of dipalmitic PC. 1.e.. with decreased surface active properties. Applied to human lung maturation in diabetic pregnancy. these findings would suggest a mechanism whereby the infant could develop RDS despite a normal lecithin/sphingomyelin ratio. an observation made repeatedly over the last decade (6.45) .
PG has recently been found to be decreabed in the amniotic fluid of human pregnant diabetics in late gestation (6) . PG may therefore be of great importance for a correct evaluation of the total surface-active properties of the fetal lung surfactant (3 1. 32).
The disturbed fetal lung maturation during pregnancy in uncontrolled. severely diabetic rats should be the subject of further investigation. Inasmuch as insulin treatment nearly normalized both altered phospholipid metabolism and lung morphology, attention could be directed toward a closer elucidation of the mechanisms underlying the persisting decrease in the LPC pathway and the possible role of PG biosynthesis in diabetic fetal pulmonary maturation.
